CAC Software vs LINQ II Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CAC Software

by 4DMedical (Imbio CAC Software)

LINQ II Insertable Cardiac Monitor

by Medtronic

AI Verdict

Tool A provides AI-powered software for analyzing CT scans to quantify coronary artery calcification, aiding in cardiovascular disease risk assessment. In contrast, Tool B is an AI-enhanced insertable cardiac monitor for long-term, continuous heart rhythm monitoring to diagnose arrhythmias. While both utilize AI in cardiology, they address different clinical problems—one focusing on structural disease imaging analysis and the other on electrical activity monitoring via an implanted device.

Choose CAC Software if…

Choose Imbio's CAC Software if your clinical workflow involves assessing cardiovascular risk in patients who have undergone non-contrast chest CT scans. This tool is ideal for radiologists and cardiologists needing automated, precise quantification of coronary artery calcification, including Agatston scores and 3D visualizations, to support early risk stratification for coronary artery disease.

View CAC Software →

Choose LINQ II Insertable Cardiac Monitor if…

Choose Medtronic's LINQ II Insertable Cardiac Monitor if you require long-term, continuous heart rhythm monitoring for patients with suspected or recurrent arrhythmias. This device is best suited for diagnosing elusive arrhythmias over extended periods (up to 4.5 years) with enhanced AI-powered accuracy and the convenience of remote programming and data transmission.

View LINQ II Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CAC Software	LINQ II Insertable Cardiac Monitor
Deployment	Cloud-based (SaaS), integrates with PACS	Subcutaneous implant with remote monitoring via mobile app or home communicator.
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CAC Software

Tool A, Imbio's CAC Software, emphasizes integration into existing DICOM viewing workflows, which streamlines the process for radiologists and cardiologists within their familiar environment. While Tool B offers remote programming and a mobile app for patients, Tool A's direct integration into professional workflows likely provides a more seamless and efficient experience for the primary clinical users.

Clinical Value

LINQ II Insertable Cardiac Monitor

Tool B, Medtronic's LINQ II, offers continuous, long-term heart rhythm monitoring for up to 4.5 years with AI-powered accuracy for diagnosing arrhythmias, including a pediatric indication. This proactive, extended monitoring for a wide range of patients, combined with its diagnostic capabilities, provides a broader and potentially more impactful clinical value compared to Tool A's snapshot risk assessment for coronary artery disease.

Pricing & Value

Tie

Both tools have opaque pricing models, requiring direct contact for quotes or enterprise negotiation, and neither publicly discloses specific costs. Without transparent pricing information or detailed cost-benefit analyses for either product, it is impossible to definitively determine which offers better value.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

Tool B, from Medtronic, benefits from being offered by a global medical device leader founded in 1949, with over a million patients having received their ICMs worldwide. This extensive track record, large customer base, and established infrastructure, alongside its FDA clearance, HIPAA compliance, and hybrid deployment options, indicate a superior level of enterprise readiness compared to Tool A.

Innovation

LINQ II Insertable Cardiac Monitor

Tool B demonstrates greater innovation by integrating AI into an implantable cardiac monitor for continuous, long-term monitoring with remote programming capabilities and a patient-facing mobile app. This comprehensive solution combines advanced hardware with AI and remote management, representing a more integrated and forward-thinking approach to patient care than Tool A's AI-powered post-processing of existing imaging data.

Support & Docs

LINQ II Insertable Cardiac Monitor

While specific details are not provided in the structured facts for either tool, Medtronic (Tool B) is a long-established, global medical device company with a vast product portfolio and customer base. This scale inherently suggests a more robust and comprehensive support infrastructure, including extensive documentation, technical support, and training resources for healthcare professionals and patients, compared to a specialized AI software company like Imbio (Tool A).

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CAC Software	LINQ II Insertable Cardiac Monitor
Name	CAC Software	LINQ II Insertable Cardiac Monitor
Description	Imbio's Coronary Artery Calcification (CAC) software is a set of automated image post-processing algorithms designed to help radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries in patients who have undergone a non-contrast, chest computed tomography (CT).	The Medtronic LINQ II is an advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias.
Company	Imbio	Medtronic
Categories	Cardiology AI	Cardiology AI, Clinical Decision Support & Reference
Specialties	Cardiology, Radiology	Cardiology
Core Function/Modality	Automated image post-processing for coronary artery calcification from non-contrast chest CT scans	Long-term, continuous heart rhythm monitoring via an insertable cardiac monitor

Videos

Demos, reviews, and walkthroughs featuring CAC Software and LINQ II Insertable Cardiac Monitor.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of each tool?

Imbio's CAC Software is designed for automated image post-processing to determine the location and quantify coronary artery calcification from non-contrast chest CT scans, aiding in coronary artery disease risk assessment. The Medtronic LINQ II Insertable Cardiac Monitor provides long-term, continuous heart rhythm monitoring with AI-powered accuracy for diagnosing arrhythmias.

How do these tools acquire and process patient data?

Imbio's CAC Software analyzes existing high-resolution non-contrast thoracic CT images using deep-learning based algorithms to generate a summary report and annotated images. The Medtronic LINQ II is an insertable cardiac monitor that records subcutaneous ECG data continuously for up to 4.5 years, utilizing AccuRhythmu2122 AI algorithms for enhanced accuracy in detecting heart rhythm events.

What specific metrics or insights do these tools provide to aid in diagnosis or risk assessment?

Imbio's CAC Software outputs the Agatston score, arterial age, and calcified lesion mass and volume, along with 3D visualizations and annotated images, to assess calcification burden. The Medtronic LINQ II provides enhanced accuracy in detecting arrhythmias, including an innovative PVC detection algorithm, and reduces false alerts for atrial fibrillation and pause events.

What is the typical patient experience or interaction with each device?

With Imbio's CAC Software, there is no direct patient interaction beyond the initial non-contrast chest CT scan, as the software analyzes existing images. For the Medtronic LINQ II, patients have an insertable device and can use the MyCareLink Heartu2122 mobile app or MyCareLink Relayu2122 home communicator for data transmission to their physician.

How do these tools integrate into existing clinical workflows?

Imbio's CAC Software is designed to integrate into existing DICOM viewing workflows, providing DICOM or PDF summary reports directly to PACS. The Medtronic LINQ II system supports remote programming and data transmission via mobile app or home communicator, enabling remote patient management and potentially reducing in-office visits.

What is the duration or scope of monitoring provided by each tool?

Imbio's CAC Software provides a non-invasive analysis from a single non-contrast chest CT scan, offering a snapshot of coronary artery calcification at that point in time. The Medtronic LINQ II offers continuous heart rhythm monitoring for an extended period of up to 4.5 years, allowing for long-term arrhythmia diagnosis and management.

Are there any specific patient populations for which each tool is particularly suited?

Imbio's CAC Software is intended for adult patients (aged 29 years and older) who have undergone a non-contrast chest CT and require assessment of coronary artery calcification for risk stratification. The Medtronic LINQ II is indicated for adult patients and has an expanded indication for pediatric patients aged 2 and older who experience transient symptoms suggesting a cardiac arrhythmia and require long-term monitoring.